An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.

Author: AvakianEdward V, BridgesTancy, FleischerAlan B, GoldMichael H, HardasBhushan, PlaumStefan

Paper Details 
Original Abstract of the Article :
Topical antifungal treatment is a mainstay of therapy for Seborrehic Dermatitis (SD). Although the amidazole and ciclopyridine antifungals have been extensively studied, few clinical efficacy data are available for topical allylamine therapy in SD. The objective of this open-label exploratory study ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/22453590

データ提供:米国国立医学図書館(NLM)

Exploring the Effectiveness of Naftifine Gel for Scalp Seborrheic Dermatitis

My fellow researchers, we are always striving to find new and effective treatments for various ailments. This particular study delves into the realm of dermatology, focusing on a common skin condition known as seborrheic dermatitis (SD). The researchers are investigating the efficacy of naftifine 1% gel in treating moderate SD of the scalp.

The study utilizes a classic approach, an open-label exploratory study, to assess both the effectiveness and safety of the naftifine gel. The researchers tracked nine subjects (5 men, 4 women) over a four-week period, monitoring their progress using various scales to evaluate their condition, including the SD Global Evaluation Scale (SDGES), Erythema Severity Scale, Scaling Severity Scale, and Itching Severity Scale. The study found that the naftifine gel was effective in reducing symptoms, leading to improvements in erythema, scaling, and itching.

Promising Results for a Common Skin Condition

The results are quite promising. The mean severity scores for SDGES and % Scalp Involvement scales showed a significant decline from baseline levels at Week 6. The study also revealed a reduction in erythema and scaling by Weeks 4 and 6. It's also heartening to see that 56% of subjects experienced improvement in itching.

A Potential Solution for Seborrheic Dermatitis

The study suggests that naftifine 1% gel is a safe and effective treatment option for moderate seborrheic dermatitis of the scalp. This finding is important, as SD is a common and sometimes stubborn condition. It's reassuring to know that there is a topical treatment option available that may offer relief to those suffering from this frustrating condition.

Dr.Camel's Conclusion

This study, like a cool oasis in the desert, offers a refreshing perspective on treating seborrheic dermatitis. The researchers' careful observation of the effectiveness of naftifine gel in mitigating symptoms provides valuable insights into a condition that can be quite bothersome. It's a testament to the ongoing quest for better treatments and a reminder that even common ailments deserve dedicated research and innovation.

Date :
  1. Date Completed 2012-07-17
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

22453590

DOI: Digital Object Identifier

22453590

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.